Editas Medicine Inc (EDIT)
$4.66 $0.12 (2.64%) 4:37 PM 07/04/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$384.05M -
Day's Range
$4.56 - $4.74 -
Volume
2,890,554 -
52 Week Low / High
$4.59 - $11.69 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 7
- Strong Buy
- 1
- Buy
- 9
- Hold
- 0
- Sell
- 0
- Strong Sell
- $13.60
- Target Price
Company News
-
Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now? — Jun 30th, 2024
We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opport...
-
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich — Jun 27th, 2024
Gene editing is a game-changer. With it, we can remove cells from your body, edit them, and then reintroduce them back into the body. All to treat cancers, blood issues, blindness, cystic fibrosis, and muscular dystrophy. All of which is creating substantial opportunities for some of the l...
-
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside Potential? — Jun 27th, 2024
We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential.In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other small-cap stocks. Small-cap stocks are companies with a market capitalization of some...
-
3 Gene Editing Stocks That Could Make Your Grandchildren Rich — Jun 25th, 2024
Gene-editing stocks has been gaining substantial attention, as the industry holds the potential to revolutionize medicine. From curing genetic disorders to enhancing agricultural productivity, the applications are vast and transformative. As of 2024, several companies are at the forefront ...